Table 1 Metabolic risk profiles and characteristics of analysis population at the most recent examination point
| Â | Most recent examination point | All | |||
|---|---|---|---|---|---|
W2 | W3 | Â | |||
Sex | |||||
Boys | Girls | Boys | Girls | ||
N (%) | N (%) | N (%) | N (%) | N (%) | |
All | 2550 (24.6) | 2543 (24.5) | 2594 (25.0) | 2672 (25.8) | 10,359 (100.0) |
DM trajectory | |||||
 Below mean | 1274 (12.3) | 1249 (12.1) | 1312 (12.7) | 1546 (14.9) | 5381 (51.9) |
 Above mean | 1276 (12.3) | 1294 (12.5) | 1282 (12.4) | 1126 (10.9) | 4978 (48.1) |
Age group | |||||
  < 12 years | 2550 (24.6) | 2543 (24.5) | 1410 (13.6) | 1428 (13.8) | 7931 (76.6) |
  ≥ 12 years | 0 (0) | 0 (0) | 1184 (11.4) | 1244 (12.0) | 2428 (23.4) |
ISCEDa | |||||
 Low | 143 (1.4) | 121 (1.2) | 147 (1.4) | 139 (1.3) | 550 (5.3) |
 Medium | 1088 (10.5) | 1089 (10.5) | 1104 (10.7) | 1160 (11.2) | 4441 (42.9) |
 High | 1297 (12.5) | 1309 (12.6) | 1323 (12.8) | 1353 (13.1) | 5282 (51.0) |
 Missing | 22 (0.2) | 24 (0.2) | 20 (0.2) | 20 (0.2) | 86 (0.8) |
 HDAS | |||||
 High | 1336 (12.9) | 1395 (13.5) | 1085 (10.5) | 1114 (10.8) | 4930 (47.6) |
 Low | 1097 (10.6) | 1013 (9.8) | 1426 (13.8) | 1469 (14.2) | 5005 (48.3) |
 Missing | 117 (1.1) | 135 (1.3) | 83 (0.8) | 89 (0.9) | 424 (4.1) |
Snack intake | |||||
 High | 1012 (9.8) | 967 (9.3) | 1643 (15.9) | 1610 (15.5) | 5232 (50.5) |
 Low | 1263 (12.2) | 1261 (12.2) | 723 (7.0) | 858 (8.3) | 4105 (39.6) |
 Missing | 275 (2.7) | 315 (3.0) | 228 (2.2) | 204 (2.0) | 1022 (9.9) |
Puberty status | |||||
 Pre-pubertal | 1123 (10.8) | 999 (9.6) | 1387 (13.4) | 1514 (14.6) | 5023 (48.5) |
 Pubertal | 0 (0.0) | 0 (0.0) | 1040 (10.0) | 1035 (10.0) | 2075 (20.0) |
 Missing | 1427 (13.8) | 1544 (14.9) | 167 (1.6) | 123 (1.2) | 3261 (31.5) |
Country | |||||
 Italy | 326 (3.1) | 297 (2.9) | 530 (5.1) | 514 (5.0) | 1667 (16.1) |
 Estonia | 269 (2.6) | 301 (2.9) | 403 (3.9) | 444 (4.3) | 1417 (13.7) |
 Cyprus | 327 (3.2) | 333 (3.2) | 524 (5.1) | 509 (4.9) | 1693 (16.3) |
 Belgium | 311 (3.0) | 303 (2.9) | 103 (1.0) | 126 (1.2) | 843 (8.1) |
 Sweden | 366 (3.5) | 361 (3.5) | 295 (2.8) | 307 (3.0) | 1329 (12.8) |
 Germany | 209 (2.0) | 215 (2.1) | 354 (3.4) | 358 (3.5) | 1136 (11.0) |
 Hungary | 359 (3.5) | 380 (3.7) | 205 (2.0) | 220 (2.1) | 1164 (11.2) |
 Spain | 383 (3.7) | 353 (3.4) | 180 (1.7) | 194 (1.9) | 1110 (10.7) |
Abdominal adiposity | |||||
 No | 1875 (18.1) | 1831 (17.7) | 1754 (16.9) | 1867 (18.0) | 7327 (70.7) |
 Yes | 664 (6.4) | 708 (6.8) | 821 (7.9) | 781 (7.5) | 2974 (28.7) |
 Missing | 11 (0.1) | 4 | 19 (0.2) | 24 (0.2) | 58 (0.6) |
Elevated BP | |||||
 No | 1944 (18.8) | 2037 (19.7) | 2109 (20.4) | 2209 (21.3) | 8299 (80.1) |
 Yes | 548 (5.3) | 443 (4.3) | 419 (4.0) | 390 (3.8) | 1800 (17.4) |
 Missing | 58 (0.6) | 63 (0.6) | 66 (0.6) | 73 (0.7) | 260 (2.5) |
Dyslipidaemia | |||||
 No | 1425 (13.8) | 1406 (13.6) | 1542 (14.9) | 1599 (15.4) | 5972 (57.7) |
 Yes | 385 (3.7) | 408 (3.9) | 315 (3.0) | 292 (2.8) | 1400 (13.5) |
 Missing | 740 (7.1) | 729 (7.0) | 737 (7.1) | 781 (7.5) | 2987 (28.8) |
Insulin resistance | |||||
 No | 1599 (15.4) | 1520 (14.7) | 1480 (14.3) | 1504 (14.5) | 6103 (58.9) |
 Yes | 442 (4.3) | 496 (4.8) | 332 (3.2) | 342 (3.3) | 1612 (15.6) |
 Missing | 509 (4.9) | 527 (5.1) | 782 (7.5) | 826 (8.0) | 2644 (25.5) |
MetS | |||||
 No | 1607 (15.5) | 1605 (15.5) | 1627 (15.7) | 1668 (16.1) | 6507 (62.8) |
 Yes | 159 (1.5) | 165 (1.6) | 127 (1.2) | 117 (1.1) | 568 (5.5) |
 Missing | 784 (7.6) | 773 (7.5) | 840 (8.1) | 887 (8.6) | 3284 (31.7) |